WIXELA INHUB
WIXELA INHUB
Approved
DIN Number
02495597
Drug Class
Human
Market Date
Feb 13, 2020
Company
HC
Mylan Pharmaceuticals ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02495597
AIG Number0238341001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03AK06 SALMETEROL AND FLUTICASONE
Product Specifications
Dosage FormPowder
Route of AdministrationInhalation
AHFS Classification12:12.08.12
Health Canada Classification
ACTIVE INGREDIENTS (2)
FLUTICASONE PROPIONATEActive
Strength: 100 MCG / ACT
Monograph: FLUTICASONE PROPIONATE
SALMETEROL (SALMETEROL XINAFOATE)Active
Strength: 50 MCG / ACT
Monograph: SALMETEROL (SALMETEROL XINAFOATE)